Gadolinium Retention as a Safety Signal: Experience of a Manufacturer

OBJECTIVES: The purpose of this manuscript is to review the successive regulatory actions and decisions following the initial publication by Kanda and colleagues in 2014 regarding gadolinium retention in the human brain after multiple gadolinium-based contrast agents (GBCAs) administrations. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Lancelot, Eric, Desché, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903321/
https://www.ncbi.nlm.nih.gov/pubmed/31725063
http://dx.doi.org/10.1097/RLI.0000000000000605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903321/
https://www.ncbi.nlm.nih.gov/pubmed/31725063
http://dx.doi.org/10.1097/RLI.0000000000000605

Ejemplares similares